HU174227B - Sposob poluchenija del'ta verkh 9/11/-5-al'fa-20-okso-steroidov - Google Patents

Sposob poluchenija del'ta verkh 9/11/-5-al'fa-20-okso-steroidov

Info

Publication number
HU174227B
HU174227B HU76SCHE569A HUSC000569A HU174227B HU 174227 B HU174227 B HU 174227B HU 76SCHE569 A HU76SCHE569 A HU 76SCHE569A HU SC000569 A HUSC000569 A HU SC000569A HU 174227 B HU174227 B HU 174227B
Authority
HU
Hungary
Prior art keywords
steroids
oxo
alpha
delta high
preparing delta
Prior art date
Application number
HU76SCHE569A
Other languages
English (en)
Hungarian (hu)
Inventor
Ulrich Kerb
Rudolf Wiechert
Otto Engelfried
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HU174227B publication Critical patent/HU174227B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
HU76SCHE569A 1975-06-11 1976-06-10 Sposob poluchenija del'ta verkh 9/11/-5-al'fa-20-okso-steroidov HU174227B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2526373A DE2526373C2 (de) 1975-06-11 1975-06-11 Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden

Publications (1)

Publication Number Publication Date
HU174227B true HU174227B (hu) 1979-11-28

Family

ID=5948981

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76SCHE569A HU174227B (hu) 1975-06-11 1976-06-10 Sposob poluchenija del'ta verkh 9/11/-5-al'fa-20-okso-steroidov

Country Status (10)

Country Link
US (1) US4061661A (enExample)
JP (1) JPS51149260A (enExample)
CH (1) CH620452A5 (enExample)
DD (1) DD125699A5 (enExample)
DE (1) DE2526373C2 (enExample)
DK (1) DK137837C (enExample)
FR (1) FR2314197A1 (enExample)
GB (1) GB1554901A (enExample)
HU (1) HU174227B (enExample)
NL (1) NL7606137A (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748442C3 (de) * 1977-10-26 1981-08-27 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4252719A (en) * 1978-08-17 1981-02-24 Research Corporation Steroid conversion method and products produced thereby
DE2929558C2 (de) * 1979-07-18 1982-03-11 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑ und/oder Δ↑1↑↑6↑ ungesättigten Steroiden
US4328162A (en) * 1980-09-05 1982-05-04 Eastman Kodak Company Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
CN119192266A (zh) 2011-10-14 2024-12-27 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
PL3498725T3 (pl) 2013-04-17 2021-11-08 Sage Therapeutics, Inc. 19-Nor C3,3-dipodstawiony C21-N-pirazolilo-steroid do zastosowania w terapii
EP2986624B1 (en) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. 19-nor neuroactive steroids for methods of treatment
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
LT3021852T (lt) 2013-07-19 2021-04-12 Sage Therapeutics, Inc. Neuroaktyvūs steroidai, jų kompozicijos ir panaudojimas
ES2706180T3 (es) 2013-08-23 2019-03-27 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024501A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
SMT202000276T1 (it) 2014-11-27 2020-07-08 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20180311258A1 (en) * 2015-04-10 2018-11-01 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
CN116162121A (zh) 2016-07-11 2023-05-26 萨奇治疗股份有限公司 C17、c20和c21取代的神经活性类固醇及其使用方法
ES2992037T3 (es) 2016-07-11 2024-12-05 Sage Therapeutics Inc Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización
WO2020082065A1 (en) * 2018-10-19 2020-04-23 Sage Therapeutics, Inc. 9(11)-unsaturated neuroactive steroids and their methods of use
EP3712161A1 (en) * 2019-03-19 2020-09-23 Bionice, S.L.U. Process for preparing high puritiy allopregnanolone and intermediates thereof
PE20230244A1 (es) 2019-05-31 2023-02-07 Sage Therapeutics Inc Esteroides neuroactivos y composiciones de estos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2681353A (en) * 1952-03-11 1954-06-15 Sterling Drug Inc Chlorination of keto-steroids
GB1380248A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy steroids and esters thereof

Also Published As

Publication number Publication date
DK137837C (da) 1978-10-23
JPS51149260A (en) 1976-12-22
DK260976A (da) 1976-12-12
FR2314197A1 (fr) 1977-01-07
NL7606137A (nl) 1976-12-14
US4061661A (en) 1977-12-06
FR2314197B1 (enExample) 1981-03-20
GB1554901A (en) 1979-10-31
DD125699A5 (enExample) 1977-05-11
DE2526373A1 (de) 1976-12-30
DE2526373C2 (de) 1983-11-10
CH620452A5 (enExample) 1980-11-28
JPS6146480B2 (enExample) 1986-10-14
DK137837B (da) 1978-05-16

Similar Documents

Publication Publication Date Title
HU177914B (en) Process for preparing 21-phenyl-sulphinyl-pregna-4,17/20/,20-trien-3-ones
HU174227B (hu) Sposob poluchenija del'ta verkh 9/11/-5-al'fa-20-okso-steroidov
GB1548032A (en) Process for preparing amono-acid admides
JPS51148725A (en) Process for producing 1*44diaminoanthraquinonee2*33 dinitril
CS191310B2 (en) Process for preparing 11-deoxy-16-aryloxy-omega-tetranorprostaglandines
JPS51136600A (en) Process for preparing gammaaferric oxide*3*
JPS51118705A (en) Process for preparing tricocenee*9* and heneicocenee*9*
CS189007B2 (en) Process for preparing 2/methoxybenzamides
JPS5259096A (en) Process for preparing gammaaferric oxide*3*
JPS5259095A (en) Process for preparing gammaaferric oxide*3*
CS191982B2 (en) Process for preparing 3,7-dimethyl-3-hydroxyoctannitrile
GB1542488A (en) Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile
JPS5283309A (en) Process for preparing 1*11dihaloo44methyll1*33pentadiene
JPS5214705A (en) Process for preparing 22chlorobutadienee1*3
JPS5246006A (en) Process for preparing 2*33dichloroo1*33butadiene
YU258476A (en) Process for preparing 2,9-dioxa-triyclo-4,3,1,0,3,7,-decanes
HU174888B (hu) Sposob poluchenija 1-naftil-n-metil-karbamata
HU174777B (hu) Sposob poluchenija 2-acilamino-oksazolov
JPS51143637A (en) Process for preparing 3*55diitertt butyll44hydroxybenzaldehyde
GB1543929A (en) Process for preparing dihalovinylcyclopropane-carboxylates
HU174633B (hu) Sposob poluchenija glikolal'degida
HU174667B (hu) Sposob poluchenija omega-amino-alkankarbonil-aril-amidov
JPS5251304A (en) Process for preparing 1*11difluoroethane
JPS51143602A (en) Process for preparing 1*11dihaloo1*33diene
JPS51136604A (en) Process for preparing 1*11dichloroo44methylpentaa1*33diene

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee